Literature DB >> 32297896

Matrix density drives 3D organotypic lymphatic vessel activation in a microfluidic model of the breast tumor microenvironment.

Karina M Lugo-Cintrón1, José M Ayuso, Bridget R White, Paul M Harari, Suzanne M Ponik, David J Beebe, Max M Gong, María Virumbrales-Muñoz.   

Abstract

Lymphatic vessels (LVs) have been suggested as a preferential conduit for metastatic progression in breast cancer, where a correlation between the occurrence of lymph node metastasis and an increased extracellular matrix (ECM) density has been reported. However, the effect of ECM density on LV function is largely unknown. To better understand these effects, we used a microfluidic device to recreate tubular LVs in a collagen type I matrix. The density of the matrix was tailored to mimic normal breast tissue using a low-density collagen (LD-3 mg mL-1) and cancerous breast tissue using a high-density collagen (HD-6 mg mL-1). We investigated the effect of ECM density on LV morphology, growth, cytokine secretion, and barrier function. LVs cultured in HD matrices showed morphological changes as compared to LVs cultured in a LD matrix. Specifically, LVs cultured in HD matrices had a 3-fold higher secretion of the pro-inflammatory cytokine, IL-6, and a leakier phenotype, suggesting LVs acquired characteristics of activated vessels. Interestingly, LV leakiness was mitigated by blocking the IL-6 receptor on the lymphatic ECs, maintaining endothelium permeability at similar levels of LV cultured in a LD matrix. To recreate a more in vivo microenvironment, we incorporated metastatic breast cancer cells (MDA-MB-231) into the LD and HD matrices. For HD matrices, co-culture with MDA-MB-231 cells exacerbated vessel leakiness and secretion of IL-6. In summary, our data suggest that (1) ECM density is an important microenvironmental cue that affects LV function in the breast tumor microenvironment (TME), (2) dense matrices condition LVs towards an activated phenotype and (3) blockade of IL-6 signaling may be a potential therapeutic target to mitigate LV dysfunction. Overall, modeling LVs and their interactions with the TME can help identify novel therapeutic targets and, in turn, advance therapeutic discovery.

Entities:  

Mesh:

Year:  2020        PMID: 32297896      PMCID: PMC7330815          DOI: 10.1039/d0lc00099j

Source DB:  PubMed          Journal:  Lab Chip        ISSN: 1473-0189            Impact factor:   6.799


  68 in total

Review 1.  Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer.

Authors:  Alexander Woywodt; Ferdinand H Bahlmann; Kirsten De Groot; Hermann Haller; Marion Haubitz
Journal:  Nephrol Dial Transplant       Date:  2002-10       Impact factor: 5.992

Review 2.  Regulation of cellular functions by extracellular matrix.

Authors:  A Teti
Journal:  J Am Soc Nephrol       Date:  1992-04       Impact factor: 10.121

3.  Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening.

Authors:  Jorn Op den Buijs; Mark Musters; Theo Verrips; Jan Andries Post; Branko Braam; Natal van Riel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07-29       Impact factor: 4.733

4.  Three-dimensional biomimetic model to reconstitute sprouting lymphangiogenesis in vitro.

Authors:  Sudong Kim; Minhwan Chung; Noo Li Jeon
Journal:  Biomaterials       Date:  2015-11-11       Impact factor: 12.479

Review 5.  Endothelial function and dysfunction: testing and clinical relevance.

Authors:  John E Deanfield; Julian P Halcox; Ton J Rabelink
Journal:  Circulation       Date:  2007-03-13       Impact factor: 29.690

Review 6.  CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.

Authors:  F Guo; Y Wang; J Liu; S C Mok; F Xue; W Zhang
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

7.  Significance of blood vessel leakiness in cancer.

Authors:  Donald M McDonald; Peter Baluk
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

Review 8.  Mechanics, malignancy, and metastasis: the force journey of a tumor cell.

Authors:  Sanjay Kumar; Valerie M Weaver
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

9.  Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration.

Authors:  I Acerbi; L Cassereau; I Dean; Q Shi; A Au; C Park; Y Y Chen; J Liphardt; E S Hwang; V M Weaver
Journal:  Integr Biol (Camb)       Date:  2015-05-11       Impact factor: 2.192

10.  RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cells.

Authors:  Marianna Gallo; Daniela Frezzetti; Cristin Roma; Nicoletta Chicchinelli; Antonio Barbieri; Claudio Arra; Giosuè Scognamiglio; Gerardo Botti; Antonella De Luca; Nicola Normanno
Journal:  Oncotarget       Date:  2018-04-03
View more
  13 in total

Review 1.  Microfluidics in vascular biology research: a critical review for engineers, biologists, and clinicians.

Authors:  Grigor Simitian; María Virumbrales-Muñoz; Cristina Sánchez-de-Diego; David J Beebe; David Kosoff
Journal:  Lab Chip       Date:  2022-09-27       Impact factor: 7.517

Review 2.  Microfluidic Biomaterials.

Authors:  Joe Tien; Yoseph W Dance
Journal:  Adv Healthc Mater       Date:  2020-09-06       Impact factor: 9.933

3.  Engineering new microvascular networks on-chip: ingredients, assembly, and best practices.

Authors:  James J Tronolone; Abhishek Jain
Journal:  Adv Funct Mater       Date:  2021-01-20       Impact factor: 18.808

Review 4.  Harnessing biomaterials for lymphatic system modulation.

Authors:  Laura Alderfer; Eva Hall; Donny Hanjaya-Putra
Journal:  Acta Biomater       Date:  2021-06-09       Impact factor: 10.633

5.  Microfluidic systems to study tissue barriers to immunotherapy.

Authors:  Ann Ramirez; Mayowa Amosu; Priscilla Lee; Katharina Maisel
Journal:  Drug Deliv Transl Res       Date:  2021-07-03       Impact factor: 5.671

6.  A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation.

Authors:  Sheena C Kerr; Molly M Morgan; Amani A Gillette; Megan K Livingston; Karina M Lugo-Cintron; Peter F Favreau; Logan Florek; Brian P Johnson; Joshua M Lang; Melissa C Skala; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2020-10-16       Impact factor: 3.177

7.  Breast Fibroblasts and ECM Components Modulate Breast Cancer Cell Migration Through the Secretion of MMPs in a 3D Microfluidic Co-Culture Model.

Authors:  Karina M Lugo-Cintrón; Max M Gong; José M Ayuso; Lucas A Tomko; David J Beebe; María Virumbrales-Muñoz; Suzanne M Ponik
Journal:  Cancers (Basel)       Date:  2020-05-06       Impact factor: 6.639

8.  Modeling Tumor: Lymphatic Interactions in Lymphatic Metastasis of Triple Negative Breast Cancer.

Authors:  Kyungmin Ji; Zhiguo Zhao; Mansoureh Sameni; Kamiar Moin; Yong Xu; Robert J Gillies; Bonnie F Sloane; Raymond R Mattingly
Journal:  Cancers (Basel)       Date:  2021-11-30       Impact factor: 6.575

Review 9.  Biomaterial Based Strategies for Engineering New Lymphatic Vasculature.

Authors:  Kevin T Campbell; Eduardo A Silva
Journal:  Adv Healthc Mater       Date:  2020-07-30       Impact factor: 11.092

Review 10.  Microfluidic lumen-based systems for advancing tubular organ modeling.

Authors:  María Virumbrales-Muñoz; José M Ayuso; Max M Gong; Mouhita Humayun; Megan K Livingston; Karina M Lugo-Cintrón; Patrick McMinn; Yasmín R Álvarez-García; David J Beebe
Journal:  Chem Soc Rev       Date:  2020-09-01       Impact factor: 60.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.